UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Lysine Restriction and Pyridoxal Phosphate Administration in a NADK2 Patient

Pediatrics (Evanston), 2016-11, Vol.138 (5)

2016

Volltextzugriff (PDF)

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

Human molecular genetics, 2004-12, Vol.13 (23), p.2997-3006

2004

Volltextzugriff (PDF)

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy

Acta neuropathologica, 2015-03, Vol.129 (3), p.399-415

2015

Volltextzugriff (PDF)

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann–Pick type C patients carrying missense mutations

The FEBS journal, 2014-10, Vol.281 (19), p.4450-4466

2014

Volltextzugriff (PDF)

Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation

Human mutation, 2017-02, Vol.38 (2), p.148-151

2017

Volltextzugriff (PDF)

Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment

Orphanet journal of rare diseases, 2015-10, Vol.10 (1), p.138-138, Article 138

2015

Volltextzugriff (PDF)

The role of the abnormalities in the distal pathway of cholesterol biosynthesis in the Conradi–Hünermann–Happle syndrome

Biochimica et biophysica acta, 2014-03, Vol.1841 (3), p.336-344

2014

Volltextzugriff (PDF)

Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency

Journal of lipid research, 2015-10, Vol.56 (10), p.1926-1935

2015

Volltextzugriff (PDF)

Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials

Advances in experimental medicine and biology, 2003, Vol.544, p.369

2003

Volltextzugriff (PDF)

Severe infantile parkinsonism because of a de novo mutation on DLP1 mitochondrial‐peroxisomal protein

Movement disorders, 2017-07, Vol.32 (7), p.1108-1110

2017

Volltextzugriff (PDF)

International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

Journal of inherited metabolic disease, 2019-05, Vol.42 (3), p.577-577

2019

Volltextzugriff (PDF)

Diagnosis and Follow-Up of a Case of Peroxisomal Disorder With Peroxisomal Mosaicism

Journal of child neurology, 1999-07, Vol.14 (7), p.434-439

1999

Volltextzugriff (PDF)

A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)

Orphanet journal of rare diseases, 2017-09, Vol.12 (1), p.155-155, Article 155

2017

Volltextzugriff (PDF)

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis

American journal of physiology: endocrinology and metabolism, 2009, Vol.59 (1)

2009

Volltextzugriff (PDF)

Modifying the peroxisomes by cell & tissue culture: II. Fibroblasts

Advances in experimental medicine and biology, 2003, Vol.544, p.265

2003

Volltextzugriff (PDF)

Autophagy induction halts axonal degeneration in a mouse model of x-adrenoleukodystrophy

Acta neuropathologica, 2015-03

2015

Volltextzugriff (PDF)

Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation: HUMAN MUTATION

Human mutation, 2017-02, Vol.38 (2), p.148-151

2017

Volltextzugriff (PDF)

Peroxisome mosaics

Advances in experimental medicine and biology, 2003, Vol.544, p.97

2003

Volltextzugriff (PDF)

Peroxisome Mosaics in the Liver of Patients and the Regulation of Peroxisome Expression in Rat Hepatocyte Cultures

Annals of the New York Academy of Sciences, 1996-12, Vol.804 (1), p.502-515

1996

Volltextzugriff (PDF)

Peroxisome Mosaics in the Liver of Patients and the Regulation of Peroxisome Expression in Rat Hepatocyte Culturesa

Annals of the New York Academy of Sciences, 1996-12, Vol.804 (1), p.502-515

1996

Volltextzugriff (PDF)

Severe infantile parkinsonism because of a de novo mutation on DLP1 mitochondrial-peroxisomal protein

Movement disorders : official journal of the Movement Disorder Society, 2017, Vol.32 (7), p.1108-1110

2017

Volltextzugriff (PDF)

Nuestra experiencia diagnóstica en enfermedades peroxisomales con alteración del perfil de ácidos grasos

Revista de neurologiá, 2008, Vol.47 (1), p.1

2008

Volltextzugriff (PDF)

Síndrome de Zellweger. Presentación de dos nuevos casos

Revista de neurologiá, 2003-06, Vol.36 (11), p.1030

2003

Volltextzugriff (PDF)

diagnóstico de las enfermedades peroxisomales en España en el período 1987-1997

Revista de neurologiá, 1999, Vol.28 (S1), p.40

1999

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(27)
Berichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lysine Restriction and Pyridoxal Phosphate Administration in a NADK2 Patient

Functional overlap between ABCD1 (ALD) and ABCD2 (ALDR) transporters: a therapeutic target for X-adrenoleukodystrophy

Diagnosis of Genetic White Matter Disorders by Singleton Whole-Exome and Genome Sequencing Using Interactome-Driven Prioritization

Autophagy induction halts axonal degeneration in a mouse model of X-adrenoleukodystrophy

The proteasome inhibitor bortezomib reduced cholesterol accumulation in fibroblasts from Niemann–Pick type C patients carrying missense mutations

Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation

Phosphomannomutase deficiency (PMM2-CDG): ataxia and cerebellar assessment

The role of the abnormalities in the distal pathway of cholesterol biosynthesis in the Conradi–Hünermann–Happle syndrome

Cholestane-3β,5α,6β-triol: high levels in Niemann-Pick type C, cerebrotendinous xanthomatosis, and lysosomal acid lipase deficiency

Evaluation of the preventive effect of glyceryl trioleate-trierucate ("Lorenzo's oil") therapy in X-linked adrenoleukodystrophy: results of two concurrent trials

Severe infantile parkinsonism because of a de novo mutation on DLP1 mitochondrial‐peroxisomal protein

International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

Diagnosis and Follow-Up of a Case of Peroxisomal Disorder With Peroxisomal Mosaicism

A quantitative assessment of the evolution of cerebellar syndrome in children with phosphomannomutase-deficiency (PMM2-CDG)

A key role for the peroxisomal ABCD2 transporter in fatty acid homeostasis

Modifying the peroxisomes by cell & tissue culture: II. Fibroblasts

Autophagy induction halts axonal degeneration in a mouse model of x-adrenoleukodystrophy

Mutations in TRAPPC11 are associated with a congenital disorder of glycosylation: HUMAN MUTATION

Peroxisome mosaics

Peroxisome Mosaics in the Liver of Patients and the Regulation of Peroxisome Expression in Rat Hepatocyte Cultures

Peroxisome Mosaics in the Liver of Patients and the Regulation of Peroxisome Expression in Rat Hepatocyte Culturesa

Severe infantile parkinsonism because of a de novo mutation on DLP1 mitochondrial-peroxisomal protein

Nuestra experiencia diagnóstica en enfermedades peroxisomales con alteración del perfil de ácidos grasos

Síndrome de Zellweger. Presentación de dos nuevos casos

diagnóstico de las enfermedades peroxisomales en España en el período 1987-1997

Suchergebnisse filtern